189 related articles for article (PubMed ID: 34634187)
1. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
2. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
3. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
4. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
[TBL] [Abstract][Full Text] [Related]
5. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania.
Campbell LR; Silverstein A; Peckham-Gregory E; Kamiyango W; Villiera J; McAtee CL; Bacha JM; Kovarik CL; Mehta PS; Chanroo T; Kapesa A; Malingoti B; Mzikamanda R; Ozuah NW; Allen CE; Scheurer ME; El-Mallawany NK
HIV Med; 2023 Jun; 24(6):664-675. PubMed ID: 36627111
[TBL] [Abstract][Full Text] [Related]
6. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
7. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
8. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.
Kamiyango W; Villiera J; Silverstein A; Peckham-Gregory E; Campbell LR; El-Mallawany NK
Cancer Metastasis Rev; 2019 Dec; 38(4):749-758. PubMed ID: 31845111
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
[TBL] [Abstract][Full Text] [Related]
12. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania.
Campbell LR; El-Mallawany NK; Slone JS; Malingoti BM; Mehta PS; Scheurer ME; Bacha JM; Peckham-Gregory EC
Pediatr Hematol Oncol; 2022 Feb; 39(1):28-47. PubMed ID: 34243680
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives.
El-Mallawany NK; McAtee CL; Campbell LR; Kazembe PN
Pediatric Health Med Ther; 2018; 9():35-46. PubMed ID: 29722363
[TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma in HIV-seronegative children presenting to the paediatric oncology ward in The Queen Elizabeth Central Hospital, Blantyre, Malawi during 2002-2014.
Mittermayer-Vassallo K; Banda K; Molyneux EM
Trop Doct; 2016 Jul; 46(3):138-42. PubMed ID: 26620689
[TBL] [Abstract][Full Text] [Related]
16. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
[TBL] [Abstract][Full Text] [Related]
17. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
18. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
19. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
[TBL] [Abstract][Full Text] [Related]
20. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
